Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Major Depressive Disorder
- Treatment Resistant Depression
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 1-Simvastatin plus TAU, 2- Placebo plus TAUMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Double blind plcaebo controlled trialPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03435744
- Collaborators
- King's College London
- Investigators
- Not Provided
Get Well Soon